MVIR — Medivir AB Income Statement
0.000.00%
Last trade - 00:00
- SEK335.00m
- SEK192.20m
- SEK7.63m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.72 | 13.9 | 25.5 | 4.41 | 7.63 |
Cost of Revenue | |||||
Gross Profit | -82.3 | -32.5 | -40.9 | -64.7 | -61.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 135 | 56.8 | 87.7 | 91.8 | 99 |
Operating Profit | -126 | -42.9 | -62.1 | -87.4 | -91.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -123 | -42.6 | -62.6 | -88.8 | -89.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -123 | -42.6 | -63.1 | -88.8 | -89.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -123 | -42.6 | -63.1 | -88.8 | -89.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -123 | -42.6 | -63.1 | -88.8 | -89.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.42 | -0.998 | -0.808 | -1.07 | -1.48 |
Dividends per Share |